Päivi received her PhD in pharmacy in 2004 and Adjunct professorship in pharmaceutical biology in 2005. She held the Academy of Finland Research Fellow position in 2014-2019, and is currently the professor of pharmaceutical biology at the Division of Pharmaceutical Biosciences, Faculty of Pharmacy. Päivi is the head of the Bioactivity Screening Group at the Faculty of Pharmacy as well as the head of High Throughput Biomedicine Unit at the Institute for Molecular Medicine Finland (FIMM).  She is expert in bioassay development and screening technologies especially in antimicrobial drug discovery.

Contact information and research profile

ORCID: 0000-0003-4697-8066

Cristina received her PhD in Food Science - Major in Microbiology from the University of São Paulo (Brazil), in 2007. After graduation, she worked as a molecular microbiologist at the Plant & Food Research Institute (New Zealand). In 2017, she joined the Bioactivity Screening Group and her research project focuses on new antimicrobials for Gram-positive bacteria.

Contact information and research profile

ORCID: 0000-0003-4655-8563

Anna Galkin received her PhD (Pharm) from the Faculty of Pharmacy, University of Helsinki, in 2008. Her thesis focused on miniaturization and automation of bioactivity screening assays. After her PhD. she worked as university lecturer at Pharmaceutical biology, Faculty of Pharmacy, University of Helsinki and made postdoctoral research visit to research groups at the National Institute of Oceanography in India and at the Technical University of Dortmund in Germany. Currently Anna is holding a position of university lecturer in Pharmaceutical Biology at the Faculty of Pharmacy, University of Helsinki. Her teaching responsibilities include both lectures and lab courses of topics of microbiology and immunology, drug discovery and pharmaceutical biology.

Contact information and research profile

Polina received her MSc (Biology) from Saint-Petersburg State University (Russia). In 2015 she completed her PhD in Biopharmacy from the University of Helsinki, where her research focused on the mechanisms of non-viral gene delivery. She joined the Bioactivity Screening Group in 2016 and focuses currently on developing cell-based assays for validation of AI-2 quorum sensing inhibitors as anti-virulence agents against Gram-negative bacteria. Polina is also instructing new users of the Bioactivity Screening core facility.

Contact information and research profile

ORCID: 0000-0002-6705-6338

Karmen received MSc (Pharm) in 2011 from University of Tartu, Estonia. In 2012, she began her doctoral studies at the Faculty of Pharmacy, University of Helsinki and received her PhD (Pharm) in 2016. Currently, Karmen is holding a position of postdoctoral researcher in Pharmaceutical Biology in the Faculty of Pharmacy, University of Helsinki. Her teaching responsibilities include courses in natural product drug discovery and microbiology. Karmen's research work focuses on natural product isolation, analytics and bioactivity screening. 

Contact information and research profile

ORCID: 0000-0002-3239-7108

Mingwei received her MSc (Pharm) in 2016 from the University of Helsinki. Currently, in her doctoral studies, her research focuses on biofilm formation and intracellular bacterial community (IBC) formation of uropathogenic E. coli (UPEC).

Contact information and research profile

Tuomas graduated from the University of Helsinki in 2013 (M.Sc. in pharmaceutical biology). Currently Tuomas is working on enteropathogenic E. coli, designing screening methods targeting a protein-protein interaction, central to the adhesion of EPEC to host cells upon infection. Previously, in his Master's thesis, he created a screening method for a neurotrophic factor (trkB).

Contact information and research profile

Saku received his MSc (Pharm) in 2020 from the University of Helsinki after studying Parkinson’s disease at the Institute of Biotechnology. Currently, in his doctoral studies, he investigates the effect of gut microbiota on the drug treatment of Parkinson’s disease in a collaborative project of the Faculty of Pharmacy.

Contact information and research profile

Heidi received her Master’s Degree in 2017 from the University of Helsinki after doing her Master’s thesis in the Bioactivity Screening Group. In her Master’s thesis, she worked on optimizing bioactivity assays used in research of AI-2 quorum sensing. Currently she is working as a Laboratory Coordinator in the Bioactivity Screening Group.

Contact information

Walter Sundberg, MSc student

Dr. Dorota Nawrot, currently at the University of Oxford
Dr. Päivi Järvinen, currently in the Chemical Microsystems Lab at the University of Helsinki

Dr. Viviana Gatta, currently at UCB Pharma, Netherlands
Dr. Katja-Emilia Lillsunde, currently at MAP Medical Technologies/Curium Pharma
Dr. Andreas Helfenstein, currently at CGI
Dr. Sofia Montalvão, currently at Borealis AG
Dr. Susanna Nybond, currently at the KTH Royal Institute of Technology/SciLifeLab
Dr. Leena Hanski (née Pohjala), currently at UH

Sampo Kurvonen, Miniaturization of a screening method to find novel inhibitors of E. coli efflux pumps (Faculty of Pharmacy, 2019)

Ulla Yrjänheikki, Assay setup for high throughput screening to identify novel efflux pump inhibitors against Escherichia coli (Faculty of Pharmacy, 2019)

Tanja Bruun, Meriperäiseen klavatadiini C -alkaloidiin perustuvien spirosyklisten yhdisteiden synteesi ja aktiivisuus melanoomasoluja vastaan (Faculty of Pharmacy, 2018)

Irene Tilli, Uudet bromityrosiinijohdannaiset ja niiden aktiivisuuden määrittäminen melanoomaa vastaan (Faculty of Pharmacy, 2018)

Heidi Mäkkylä, Gramnegatiivisten bakteerien viestintä ja AI-2-välitteisen signaloinnin häirintä (Faculty of Agriculture and Forestry, 2017)

Jutta Karppinen, 3D liver cell models and automation as tools for drug development (Faculty of Pharmacy, 2017)

Jenna Kuusjärvi, Escherichia coli: Resistenssitilanne ja bioreportterimenetelmän hyödyntäminen antimikrobisen aktiivisuuden seulonnassa (Faculty of Pharmacy, 2016)

Laura Kenttä, Luminoivien bakteerikantojen käyttö antimikrobiseulonnassa (Faculty of Pharmacy, 2015)

Sara Bož, Comparison of bioluminescent Escherichia coli K-12/pTetLux1 and WZM120/pCGLS-11 strains in the evaluation of antibacterial activity (University of Ljubljana, Slovenia, 2015)

Kira Holvikari, Characterising MRP2 inhibitors, stimulators and substrates from a library of natural compounds and pharmaceutical excipients (Faculty of Pharmacy, 2015)

Noora Jokinen, Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances (Faculty of Pharmacy, 2013)

Tuomas Pylkkö, Keskushermostossa sijaitsevan lääkekohteen tehoseulomiseen liittyviä erityispiirteitä (Faculty of Pharmacy, 2013)

Soile Kuosmanen, Assay optimization and validation for screening marine extracts against Mycobacterium smegmatis (Faculty of Pharmacy, 2013)

Katja-Emilia Lillsunde, Screening for marine-derived inhibitors of Chikungunya virus replication (Faculty of Pharmacy, 2012)

Elina Pekonen, Oksidatiivinen stressi Fusarium avenaceum –mykotoksiinien toksisuuden mekanismina? (University of Turku/TERBIO Master Degree Program, 2012)

Juho Tuhkalainen, Luonnonaineiden kemiallinen muokkaus lääkeaineiksi ja abietiinihappojohdannaisten biologisen aktiivisuuden tutkiminen (Faculty of Pharmacy, 2012)